This suggests that L delbrueckii is not involved in the hypoglycemic and weight loss effects of GLP-1 RAs used in the treatment of T2DM, and that GLP-1 RAs have no direct effect on L delbrueckii abundance in the gut. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.